Literature DB >> 16052027

Dose adjustment in renal impairment: response from AHFS Drug Information.

Gerald K McEvoy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16052027      PMCID： PMC1181276          DOI： 10.1136/bmj.331.7511.293

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  1 in total

1.  Systematic comparison of four sources of drug information regarding adjustment of dose for renal function.

Authors:  Liat Vidal; Maya Shavit; Abigail Fraser; Mical Paul; Leonard Leibovici
Journal:  BMJ       Date:  2005-05-19
  1 in total
  4 in total

1.  Presence and accuracy of drug dosage recommendations for continuous renal replacement therapy in tertiary drug information references.

Authors:  Sean K Gorman; Richard S Slavik; Stefanie Lam
Journal:  Can J Hosp Pharm       Date:  2012-05

2.  Clinical relevance of information in the Summaries of Product Characteristics for dose adjustment in renal impairment.

Authors:  Teresa M Salgado; Blanca Arguello; Fernando Martinez-Martinez; Shalom I Benrimoj; Fernando Fernandez-Llimos
Journal:  Eur J Clin Pharmacol       Date:  2013-07-25       Impact factor: 2.953

3.  Incidence, Risk Factors, and Clinical Outcomes of Acute Kidney Injury Caused by Palliative Chemotherapy in Lung Cancer.

Authors:  Song Ee Park; Jin Ho Hwang; Jin Hwa Choi; Su-Hyun Kim; Jae Chol Choi; Joung Soon Jang; Hee Jun Kim; Suk Won Park; Ju Won Seok; In Gyu Hwang
Journal:  J Cancer       Date:  2019-08-29       Impact factor: 4.207

4.  Chinese herbal component, Praeruptorin E, enhances anti-asthma efficacy and prevents toxicity of aminophylline by targeting the NF-κB/PXR/CYP3A4 pathway.

Authors:  Ronghua Xu; Huiming Deng; Lianfang Gan; Lifan Zhong; Yanxi Deng; Qianru Wang; Chuanzhu Lv; Ling Huang
Journal:  Ann Transl Med       Date:  2022-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.